| 2024/07/12 21:48:01 | |
|---|---|
| Price | |
| 0.95 USD | |
| Difference | -13.64% (-0.15) |
General attributes
| ISIN | CH1262055788 |
| Symbol | EVE |
| Exchange | FINRA other OTC Issues |
| Currency | USD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 7 EUR |
| Benchmark | SWISS MARKET INDEX |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | 0.95 USD |
| High | 0.95 USD |
| Low | 0.95 USD |
| Close (prev. day) | 1.10 USD |
| VWAP | 0.95 USD |
| Volume (pcs) | 1,988 |
| Trading volume | 1,888.60 |
| Number of trades | 2 |
| Last size | 798 |
Futures and Options
| Related Futures | - |
| Related Options | - |
PDF Downloads
| Company report: EVOLVA HOLDING SA |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/07/12 |
|
Global Equity Ratings |
|
| 2024/06/21 |
|
Global Equity Ratings |
|
| 2024/06/14 |
|
Global Equity Ratings |
|
| 2024/05/29 |
|
Global Equity Ratings |
|
| 2024/04/26 |
|
Global Equity Ratings |
|
| 2024/07/12 21:48:01 | |
|---|---|
| Price | |
| 0.95 USD | |
| Difference | -13.64% (-0.15) |
General attributes
| ISIN | CH1262055788 |
| Symbol | EVE |
| Exchange | FINRA other OTC Issues |
| Currency | USD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 7 EUR |
| Benchmark | SWISS MARKET INDEX |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | 0.95 USD |
| High | 0.95 USD |
| Low | 0.95 USD |
| Close (prev. day) | 1.10 USD |
| VWAP | 0.95 USD |
| Volume (pcs) | 1,988 |
| Trading volume | 1,888.60 |
| Number of trades | 2 |
| Last size | 798 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | +11.05% | -80.04% | -97.89% |
| Perf (abs.) | +0.09 | -3.81 | -44.16 |
| Beta | 0.72 | -0.40 | 0.44 |
| Volatility | - | 356.18 | 879.98 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | - USD (-) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 0.95 USD (67) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 1.02 USD (23) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 1.41 USD (21) |
| YTD High | date | 1.10 USD (2024/04/01) |
| YTD Low | date | 0.95 USD (2024/07/12) |
| 52 Weeks High | date | 3.09 USD (2023/08/30) |
| 52 Weeks Low | date | 0.82 USD (2023/12/05) |
All listings for EVOLVA HOLDING SA
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Berlin | 2019/06/28 | 15:58 | 43.45 EUR | 0.00 | 5 |
| FINRA other OTC Issues | 2024/07/12 | 21:48 | 0.95 USD | 0.00 | 2 |
| Frankfurt | 2019/06/28 | 09:05 | 41.90 EUR | 0.00 | 2 |
| London Stock Exchange | 2019/06/28 | 10:08 | 49.50 CHF | 0.00 | 1 |
| SIX Swiss Exchange | 2024/07/17 | 17:30 | 0.90 CHF | 0.00 | 17 |
Company Logo
Contact Details
| EVOLVA HOLDING SA |
| - - |
| Duggingerstrasse 23 - 4153 Reinach |
| Telefon: +41-61-485-20-00 |
| Fax: +41-61-485-20-01 |
| E-mail: info@evolva.com |
PDF Downloads
| Company report: EVOLVA HOLDING SA | |
Company Profile
Evolva Holding SA engages in the business of researching, developing, and commercializing novel nutritional, healthcare, and wellness ingredients. It operates through the following business segments: Flavors and Fragrances, Health Ingredients, and Health Protection. The Flavors and Fragrances segment includes L-Arabinose, Valencene, Nootkatone, and Vanillin. The Health Ingredients segment focuses on NootkaSHIELD. The Health Protection segment is involved in designing, manufacturing, and supplying nature-based products with high efficacy that can protect health-conscious consumers. The company was founded by Alexandra Santana Sørensen, Søren V. S. Nielsen, and Neil Goldsmith in 2004 and is headquartered in Reinach, Switzerland. |
Members of Management Board
| Christian Wichert | Chairman of Managing Board |
| Anne De Vos | Member of Executive Committee |
| Carsten Däweritz | Member of Executive Committee |
| Gerhard Lobmaier | Member of Executive Committee |
Board of directors
| Beat In-Albon | Member of the administrative board |
| Christoph Breucker | Member of the administrative board |
| Andreas Pfluger | Member of the administrative board |
| Andreas Weigelt | Member of the administrative board |
| Stephan Schindler | Chairman of the administrative boar |